Mechanical Circulatory Support
The UCSF Mechanical Circulatory Support (MCS) Program cares for patients with advanced heart failure using various types of mechanical heart pumps. These pumps – called left ventricular assist devices, or LVADs – can improve quality of life for patients who are awaiting heart transplant, as well as those with no remaining options aside from end-of-life care. They may also be used to allow a failing heart to rest until other treatment options become viable.
When your heart failure symptoms become overwhelming and medications don't seem to be helping any longer, it is time to discuss other options with your cardiologist. Your doctor will talk to you about mechanical circulatory support therapy and can make a referral to our center to meet with the MCS cardiologist or surgeon. A referral is required to make an appointment with our program.
A referral to a different doctor does not mean that you can no longer be seen by your own cardiologist; he or she will follow up with you after your surgery, if it is determined that LVAD therapy is right for you.
If you haven't already done so, you will need to undergo several tests, which the MCS physicians will review to determine whether you are a good candidate for LVAD therapy. These tests include echocardiogram, heart catheterization and pulmonary function tests. You may need additional testing after you have seen the MCS physicians.
After the team has reviewed all your test results, your MCS physician will contact you to discuss whether LVAD is the best treatment for your heart failure.
Doctor referral required
Randomized Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who...
MAE defined as: All-cause death, Myocardial infarction, Stroke, Need for non-elective cardiovascular surgery, Worsening of heart-failure requiring mechanical circulatory support for more than 24 hours Acute kidney injury req...
remedē System Therapy Study
Percentage of patients with related serious adverse events.
Pulmonary Hypertension Association Registry
PAH guideline-recommended diagnostics assessed include chest radiography, echocardiogram, ventilation-perfusion (V/Q) scan, pulmonary function tests, overnight oximetry, and right heart catheterization and identified as either "co...
Reducing Right Ventricular Failure in Pulmonary Arterial Hypertension (RELIEVE-PAH)
Percentage of Treatment group patients experiencing any device-related Major Adverse Cardiovascular or Neurological Events (MACNE) during the first 90-days after implantation
Tailored Drug Titration Using Artificial Intelligence
optima4BP leads ≥4mmHg of SBP reduction compared to Standard of Care
Right Ventricular Pacing in Pulmonary Arterial Hypertension
This is an invasive measure of the contractile strength of the right ventricle that is measured using pressure volume measurements from within the ventricle itself.
Remote Dielectric Sensing (ReDS) Assisted Diuresis in Acute Decompensated Heart Failure
Cumulative net fluid balance assessed by In's and Out's recorded in the Electronic Medical Record (EMR) during hospitalization
Awards & recognition
Best hospital in Northern California
lower rate of hospital readmissions
lower rate of most complications
Plan your visit
What to Bring
- Photo I.D.
- Health insurance card
- Insurance authorization, if required
- Doctor's referral, if required
- Recent test results related to your condition
- List of your medications, including dosages, plus any you're allergic to
- List of questions you may have
- Device or paper for taking notes
Our research initiatives
UCSF Heart Failure and Pulmonary Hypertension Research
The UCSF Division of Cardiology conducts research aimed at improving the understanding and treatment of pulmonary hypertension and heart failure.